Alectinib hydrochloride is a hydrochloride salt form of alectinib, a selective inhibitor of anaplastic lymphoma kinase (ALK). It is used as a pharmaceutical raw material for the manufacturing of medications indicated for ALK-positive metastatic non-small cell lung cancer.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1256589-74-8
Alectinib
active pharmaceutical ingredient
8-AZAGUANINE
antineoplastic agent
Chimmitecan
antineoplastic agent
Ixabepilone
antineoplastic agent
Duocarmycin DM free base
antineoplastic agent
(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]carbamoylamino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
active pharmaceutical ingredient
Prochlorperazine edisylate
active pharmaceutical ingredient
Venetoclax
active pharmaceutical ingredient
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
GYABBVHSRIHYJR-UHFFFAOYSA-N
CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C.Cl